Fortis Healthcare Reaches 52-Week High, Shows Strong Performance in Market
Fortis Healthcare's stock price has reached a 52-week high of Rs. 576.9, indicating a positive trend for the company. According to MarketsMojo, the current stock call for Fortis Healthcare is 'Hold', with a steady growth trend and consecutive gains in the last 4 days. The company's strong performance and outperformance of the Sensex make it a promising investment option in the largecap category.
Fortis Healthcare, a leading hospital and healthcare services company, has recently reached a new milestone with its stock price touching a 52-week high of Rs. 576.9 on September 12, 2024. This comes as a positive sign for the company, as it continues to perform well in the market.
According to MarketsMOJO, a leading stock market analysis platform, the current stock call for Fortis Healthcare is 'Hold'. This indicates that the stock is expected to maintain its current performance and is not recommended for buying or selling at the moment.
The stock's performance today has been in line with the overall sector, showing a steady growth trend. In fact, Fortis Healthcare has been on a consecutive gain for the last 4 days, with a 5.15% increase in returns during this period. This is a positive indication for investors, as the company continues to show a strong performance in the market.
In terms of moving averages, Fortis Healthcare is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This further reinforces the company's strong performance and positive outlook in the market.
When compared to the Sensex, Fortis Healthcare has shown an impressive 1-year performance of 71.07%, while the Sensex has only seen a 21.49% growth during the same period. This highlights the company's strong position in the market and its ability to outperform the overall market trends.
Overall, Fortis Healthcare's recent achievement of reaching a 52-week high and its consistent performance in the market make it a promising investment option for investors. With its strong presence in the hospital and healthcare services industry and a track record of steady growth, Fortis Healthcare is definitely a company to watch out for in the largecap category.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
